Thyroid Medication Recall Elevated to Highest Warning Level: FDA
NEED TO KNOW The FDA has elevated the recall of a thyroid medication to Class I, due to…
Blood Pressure Drug Recalled Nationwide, FDA Announces
When a prescription drug is recalled, often it’s a generic version that’s being pulled from market. But this…
Lilly to file for next-gen obesity drug approval in early 2027
Investing.com — Eli Lilly announced Thursday it will file for approval of its next-generation obesity drug retatrutide in…
New Weight Loss Drugs Preserve Muscle and Cut Fat
Nearly every pharmaceutical company you can name is chasing this tantalizing idea: hang on to your muscles while…
This Healthcare Stock With 6%-Plus Yield: Is the Dividend Safe?
Pfizer (NYSE: PFE) is facing patent expirations for some of its biggest drugs. That’s normal for a pharmaceutical…
Insmed’s ‘ginormous’ lung drug sales; J&J’s US pricing deal
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
These 2 Healthcare Stocks Just Declared Dividend Raises
While the pre-holiday season isn’t usually a busy time for dividend raises, investors can usually expect a few…
What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill.
Skyrizi and Rinvoq sales are pushing AbbVie’s sales higher. UnitedHealth Group raised its full-year guidance and is rebounding…
Ozempic at Costco? Discount Giant Expands Into $100 Billion Weight-Loss Drug Market
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Costco…
Is LLY Underperforming the Healthcare Sector?
With a market cap of $694.9 billion, Eli Lilly and Company (LLY) is a leading global pharmaceutical company headquartered…
3k job cuts spark $20bn sell-off
CSL has announced it will slash 3000 roles. Picture: NewsWire / Nicholas Eagar Australia’s largest pharmaceutical company could…